Pharmaceuticals

DIPP throws spanner in 100% pharma sector FDI plan

06 Jul 2013

China launches probe on GSK over price fixing

05 Jul 2013

S Africa’s Adcock Ingram receives $1.3-bn bid from Chile’s CFR Pharma

04 Jul 2013

Sale of Turkish pharmaceutical company Sanovel may fetch upto $1 bn

03 Jul 2013

Swiss drugmaker Roche buys US blood testing company CMI for $220 mn

02 Jul 2013

Biotechnology company Onyx rejects Amgen’s $10 -bn takeover bid

01 Jul 2013

Diclofenac painkiller linked to heart attack, stroke: study

29 Jun 2013

Amgen eyes $10-bn cash deal with Onyx Pharmaceuticals: report

29 Jun 2013

Germany’s Fresenius sells biotechnology business to Israel’s Fuhrer family

28 Jun 2013

Russian biotechnology firm Biocad seeks buyers: report

27 Jun 2013

Aspen Pharmacare to buy API business from Merck in $1 billion deal

27 Jun 2013

LifeLabs Medical Laboratory to buy CML HealthCare for $1.16 bn

25 Jun 2013

Russia's Pharmstandard mulls selling OTC business: report

25 Jun 2013

KKR & Co acquires clinical research group PRA for a reported $1.3 bn

25 Jun 2013

SC throws out PIL against Ranbaxy over substandard drug issue

25 Jun 2013

Ranbaxy, the largest drug maker in India, is under attack, both because of its size and reach and the threat its generic drugs pose to the patent drugs lobby, especially in the West

European regulator fines Ranbaxy and 8 others for blocking generic drugs

19 Jun 2013

The European antitrust regulator today fined nine pharmaceutical companies including Ranbaxy a total of €146 million for blocking the supply of a cheaper anti-depressant drug to the market.

Glenmark receives US health regulator approval for Riluzole tablets

19 Jun 2013

Aspen Pharma offers to buy GlaxoSmithKline’s thrombosis brands

18 Jun 2013

J&J to buy Aragon Pharmaceuticals; deal potential $1 bn

17 Jun 2013

Elan shareholders approve share-repurchase program jeopardising Royalty’s bid

17 Jun 2013

No patents on human DNA, unless synthetic: US Supreme Court

14 Jun 2013

With the US Supreme Court ruling yesterday that DNA was part of nature and no one could patent it, the curtain has fallen on one of the most hotly debated topics in recent times

Zydus US subsidiary to recall one lot of Warfarin blood thinner in US markets

13 Jun 2013

Sun Pharma settles Teva patent spat with Pfizer for $550 mn

13 Jun 2013

Teva, Sun Pharma to pay Pfizer $2.15 bn to settle patent suit

12 Jun 2013

Teva, the world’s largest generic drug firm, will pay $1.6 billion of the settlement amount while Sun Pharmaceuticals will pay the remaining $550 million

Six private, PSU firms keen to buy Haldia Petrochem stake

11 Jun 2013